_Easy-Resize.com.jpg)
Dr. Irit Yaniv is the Founding Partner and CEO of Almeda Ventures, a public venture fund traded on the Tel Aviv Stock Exchange, focused on investments in medical devices, digital health, and bioconversion. With 15 years of increasing responsibilities in the life sciences industry, Dr. Yaniv has a robust background in managing product development from inception through launch, designing and implementing clinical studies, achieving FDA regulatory approvals, and driving sales growth. As an investor, she has led several companies through successful M&A transactions and continues to seek strategic acquisitions within Almeda's portfolio.
While most investors have a passive role in their portfolio company, some investors are active in shaping and contributing to its success. For venture capitalists, one of the best scenarios is for the portfolio company to be acquired to maximize investment returns. In this interview, Dr. Irit Yaniv, Founding Partner and CEO at Almeda Ventures discusses what investors can do when planning and executing the exit.